Sensor-based gait analysis in atypical parkinsonian disorders

Area of Science:

• Neurology
• Biomedical Engineering
• Movement Disorders

Background:

• Gait impairment and reduced mobility are characteristic of idiopathic Parkinson's disease (iPD) and atypical parkinsonian disorders (APD).
• Quantitative gait assessment is valuable for diagnosing parkinsonian disorders and serving as an endpoint in clinical trials.
• Differentiating between iPD and APD is crucial for appropriate patient management and treatment strategies.

Purpose of the Study:

• To identify quantitative gait parameter differences between iPD and APD patients using sensor-based gait analysis.
• To correlate specific gait parameters with clinical rating scales in both patient groups.
• To evaluate the utility of instrumented gait analysis in distinguishing parkinsonian disorders.

Main Methods:

• Patients with iPD and APD (including multiple system atrophy and progressive supranuclear palsy) were recruited and matched for age, gender, and Hoehn and Yahr stage.
• Standardized clinical rating scales (MDS-UPDRS-3, UMSARS, PSP-RS) were used for clinical assessment.
• Spatiotemporal gait parameters were objectively measured using inertial sensor units attached to shoes during 4x10m walk tests.

Main Results:

• Sensor-based gait analysis revealed significantly reduced gait speed and stride length in APD patients compared to iPD patients.
• Clinical ratings demonstrated a significant correlation with gait speed and stride length specifically in APD patients.
• Instrumented gait analysis provided objective, rater-independent gait metrics.

Conclusions:

• APD patients exhibit more severe gait impairments than iPD patients, even when disease severity is comparable.
• Instrumented gait analysis offers valuable, objective quantitative parameters for clinical trials and patient care in parkinsonian disorders.
• Objective gait assessment can aid in the diagnostic workup and management of patients with parkinsonian syndromes.